On March 21st, 2024, Grupa Żywiec Sp. z o.o. (“Grupa Żywiec”) entered into the agreement with Mycofeast LTD (“Mycofeast”) on the disposal of a large-scale former brewery from Grupa Żywiec located in Leżajsk (“Browar Leżajsk”). The closing of the transaction is subject to customary closing conditions, including obtaining the approval of the antimonopoly authorities. The terms of the transaction remain undisclosed.
Browar Leżajsk was one of the five beer production facilities operated in Poland with a production of approximately 800,000 hectolitres of beer in 2021. Following the decision to reorganize its production in Poland back in February 2023, Grupa Żywiec officially ceased production of beer at Browar Leżajsk at the end of August 2023. In the meantime a sale process of Browar Leżajsk was initiated with Vienna Capital Partners is acting as exclusive financial advisor to Grupa Żywiec.
Mycofeast is an industrial biotechnology company that harnesses biomass fermentation to develop high-quality proteins, specialty lipids, and critical ingredients for the food and animal feed sectors.
With the acquisition of Browar Leżajsk, Mycofeast will acquire more than 8,000 m3 of fermentor capacity in a modern and well invested facility. Through this investment, Mycofeast will gain access to skilled technical expertise, feedstock, excellent quality water, and every essential production resource. Moving forward, Mycofeast plans to adopt a B2B model, leveraging partnerships with leading technology, food, feed, and ingredient companies to integrate its innovative products into the market effectively.
“We are thrilled to embark on this journey in Leżajsk and to leverage the brewery’s existing infrastructure for our ambitious growth plan,” said Witold Hruzewicz, one of the founders of Mycofeast. “Our goal is not just to create a robust business model, but to make a tangible impact on sustainable food production. We are already collaborating with a number of academics at leading universities and corporate partners for our biology.”